SLCTR_2017_041
Comparison of sodium excreting effect between furosemide and indapamide combination with furosemide and metolazone combination in congestive heart failure patients
A randomized controlled trial to compare the efficacy of furosemide and indapamide combination against furosemide and metalozone combination in the sodium excreting effect in congestive heart failure
Rehman Medical Institute·Not Applicable·Sri Lanka Clinical Trials RegistryCompleted
Study focus
- Disease/Condition
- Congestive Heart Failure
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Rehman Medical Institute
- Location
- Pakistan
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- Jan 01, 2018
- End date
- N/A
ICD-10 classifications
Congestive heart failureHeart failureHypertensive heart disease with (congestive) heart failureHypertensive heart and renal disease with (congestive) heart failureHeart failure, unspecified
Data source
- Registry
- Sri Lanka Clinical Trials Registry
- Trial ID
- SLCTR_2017_041
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for SLCTR_2017_041 through Pure Global AI's free database. This Not Applicable trial is sponsored by Rehman Medical Institute and is currently Completed. The study focuses on Congestive Heart Failure.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.